Sensus Healthcare, Inc. Announces Completion of Initial Public Offering, including Underwriters’ Exercise of Over-Allotment Option in Full

BOCA RATON, Fla., June 8, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced the completion of its initial public offering of 2,300,000 units at a public offering price of $5.50 per […]

ASDS: Skin Cancer Treatments Among Most Frequently Performed Procedures in 2015

Dermatologic surgeons performed nearly 10 million medical and cosmetic procedures in 2015 – up five percent since 2014 and 27 percent since 2012, according to the 2015 American Society for Dermatologic Surgery (ASDS) Survey on Dermatologic Procedures. For the fourth year in a row, skin cancer treatments ranked as the most-performed procedure (3.17 million) by ASDS members. […]

Sensus Healthcare Introduces Superficial Radio Therapy By The SRT-100™ As A Mobile Unit For Doctors

Sensus Healthcare is revolutionizing skin cancer treatment with the SRT-100™, a Superficial Radio Therapy machine that provides a non-surgical option for treatment of non-melanoma cancer. There is now a mobile unit of the SRT-100™ available. This technology can be delivered to hospitals and benefits you as a doctor because it prevents you from having to […]

Sensus Healthcare Introduces Superficial Radiotherapy As A Mobile Unit For Immobile Patients

Sensus Healthcare is revolutionizing skin cancer treatment with the SRT-100™, a Superficial Radiotherapy machine that provides a non-surgical option for treatment of non-melanoma cancer. There is now a mobile unit of the SRT-100™ available, allowing you to forget the hospital and waiting rooms. Superficial Radiotherapy, a highly effective option in the treatment of basal and squamous […]

Single Fraction Radiotherapy For Small Superficial Carcinoma Of The Skin

Chan S, Dhadda AS, Swindell R. Single fraction radiotherapy for small superficial carcinoma of the skin.ClinOncol (R CollRadiol). 2007 May;19(4):256-9. Epub 2007 Mar 26. Department of Clinical Oncology, Nottingham University Hospital NHS Trust, Hucknall Road, Nottingham NG5 1PB, UK. steve.chan@nuh.nhs.uk AIMS: To define the optimal dose and maximum tumour size of basal and squamous cell carcinoma […]

Non-Surgical Treatments Of Primary, Non-Melanoma Eyelid Malignancies: A Review

Murchison AP, Walrath JD, Washington CV. Non-surgical treatments of primary, non-melanoma eyelid malignancies: a review. Clin Experiment Ophthalmol. 2011 Jan;39(1):65-83; quiz 92-3. doi: 10.1111/j.1442-9071.2010.02422.x. Epub 2011 Jan 31. Oculoplastic and Orbital Surgery Service, Wills Eye Institute, Philadelphia, Pennsylvania 19107, USA. amurchison@willseye.org The diagnosis and management of periocular cutaneous malignancies are essential components of an ophthalmologist’s […]

Palliative Radiotherapy For Non-Melanoma Skin Cancer

Barnes EA, Breen D, Culleton S, Zhang L, Kamra J, Tsao M, Balogh J. Palliative radiotherapy for non-melanoma skin cancer. ClinOncol (R CollRadiol). 2010 Dec;22(10):844-9. Epub 2010 Aug 15. Department of Radiation Oncology, Odette Cancer Centre, Toronto, Ontario, Canada. toni.barnes@sunnybrook.ca AIMS: The primary objective of this study was to assess the rate of tumor response to the […]